Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KRT8 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | ZNF337 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
mRNA | MTHFS | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
mRNA | APOC2 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
mRNA | CERKL | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
mRNA | FAM133A | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
mRNA | ACOT12 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
mRNA | MIA-RAB4B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | MAST1 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
mRNA | ENO2 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |